statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Director N Coles Sells 50,000 Shares of Cerevel Therapeutics Holdings Inc (CERE)

This is a signal that CERE's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Cerevel Therapeutics Holdings (CERE, $42.32) RSI Indicator left the overbought zone on March 19, 2024

Cerevel Therapeutics Holdings (CERE, $42.58) RSI Indicator left the overbought zone on March 18, 2024

Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE  Get Free Report) Director N Anthony Coles sold 50,000 shares of the companys stock in a transaction that occurred on Monday, March 4th...

Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Director Sells $2,050,500.00 in Stock

Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE  Get Free Report) has been given an average recommendation of Hold by the eleven ratings firms that are presently covering the...

Analysts Set Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Target Price at $39.64

Investors in Cerevel Therapeutics Holdings Inc (CERE) saw new options become available this week, for the March 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and...

First Week of CERE March 15th Options Trading

Investors in Cerevel Therapeutics Holdings Inc (CERE) saw new options begin trading this week, for the August 16th expiration. One of the key inputs that goes into the price an option buyer is...

First Week of August 16th Options Trading For Cerevel Therapeutics Holdings (CERE)

Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE  Get Free Report) Director N Anthony Coles sold 2,506 shares of Cerevel Therapeutics stock in a transaction dated Wednesday, February 7th. The...

Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Director N Anthony Coles Sells 2,506 Shares

Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE  Get Free Report) insider John Renger sold 2,161 shares of the firms stock in a transaction that occurred on Wednesday, February 7th...

Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Insider Sells $89,767.94 in Stock

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Cerevel Therapeutics Holdings Inc (CERE) was identified as having a larger market cap than the smaller...

Cerevel Therapeutics Holdings Larger Than S&P 500 Component Norwegian Cruise Line Holdings

Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. Its product candidates include CVL-231, Darigabat, Tavapadon, CVL-871, and CVL-936. The company was founded in 2018 and is headquartered in Cambridge, MA.

Volume	912,342.00
52-Wk High	$43.59
52-Wk Low	$19.59

CERE Cerevel Therapeutics Holdings Inc

About

Feed

News

Sentiment

Earnings

Fundamentals